Related Experiment Video
Updated: Sep 19, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Magnesium deficiency and dilated cardiomyopathy diagnosed peripartum
Adam Morton1,2
1Departments of Obstetric Medicine and Endocrinology, Mater Health, South Brisbane, QLD, Australia.
Insights
Pregnancy-related dilated cardiomyopathy may be linked to low magnesium levels (hypomagnesaemia). This condition, characterized by heart muscle enlargement, warrants further investigation into magnesium
Area of Science:
- Cardiology
- Obstetrics
- Biochemistry
Background:
- Dilated cardiomyopathy during pregnancy poses significant risks for maternal health.
- Low magnesium levels (hypomagnesaemia) are linked to arrhythmias and heart conditions in the general population.
- Pregnancy naturally lowers serum magnesium, and intracellular deficiency can occur even with normal serum levels.
Purpose of the Study:
- To present cases of peripartum dilated cardiomyopathy associated with hypomagnesaemia.
- To review the existing literature on magnesium deficiency and dilated cardiomyopathy.
- To propose future research directions and discuss management implications.
Main Methods:
- Case study presentation of three women with peripartum dilated cardiomyopathy and hypomagnesaemia.
- Comprehensive literature review on magnesium's role in cardiovascular health and dilated cardiomyopathy.
- Discussion of potential research avenues and clinical management strategies.
Main Results:
- Three cases illustrate the occurrence of dilated cardiomyopathy in the peripartum period concurrent with hypomagnesaemia.
- Literature review supports an association between magnesium deficiency and dilated cardiomyopathy.
- Hypomagnesaemia may be a contributing factor to dilated cardiomyopathy in pregnancy.
Conclusions:
- Hypomagnesaemia may play a role in the development of peripartum dilated cardiomyopathy.
- Further research is needed to establish a causal link and explore magnesium repletion strategies.
- Considering magnesium status may be important in managing pregnant women with dilated cardiomyopathy.
Abstract:
Dilated cardiomyopathy in pregnancy, whether diagnosed pre-conception, or occurring de novo during pregnancy, may be associated with significant maternal morbidity and mortality. Hypomagnesaemia is associated with ventricular arrhythmias and may be a risk factor for heart failure, coronary artery disease and atrial fibrillation in the general population. Pregnancy is associated with a progressive physiological fall in serum magnesium concentration. Intracellular magnesium deficiency may exist despite normal serum magnesium concentration. Three cases of dilated cardiomyopathy developing in the peripartum period with hypomagnesaemia are presented. The literature regarding associations between magnesium deficiency and dilated cardiomyopathy is reviewed. Potential future research examining magnesium deficiency as a potential contributor to dilated cardiomyopathy in pregnancy is proposed, and possible implications for management are discussed.
More Related Videos
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests